silybin has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cui, L; Hattori, S; Hayashi, T; Ikejima, T; Liu, B; Liu, P; Liu, W; Mizuno, K; Onodera, S; Ushiki-Kaku, Y | 1 |
| Choi, MS; Jeon, MT; Jung, UJ; Kim, SR | 1 |
2 other study(ies) available for silybin and Nerve Degeneration
| Article | Year |
|---|---|
Silibinin ameliorates STZ-induced impairment of memory and learning by up- regulating insulin signaling pathway and attenuating apoptosis.
Topics: Animals; Apoptosis; Cerebral Cortex; Cognitive Dysfunction; Diabetes Mellitus, Experimental; Hippocampus; Insulin; Insulin-Like Growth Factor I; Male; Memory Disorders; Nerve Degeneration; Neuroprotective Agents; Phosphorylation; Rats; Signal Transduction; Silybin; Streptozocin; tau Proteins | 2020 |
Silibinin attenuates MPP⁺-induced neurotoxicity in the substantia nigra in vivo.
Topics: 1-Methyl-4-phenylpyridinium; Animals; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Female; Inflammation; Interleukin-1beta; Microglia; Nerve Degeneration; Neuroprotective Agents; Nitric Oxide Synthase Type II; Parkinson Disease; Rats; Rats, Sprague-Dawley; Silybin; Silymarin; Substantia Nigra; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2014 |